- Pharmaceutical Technology, Trends in Formulation, October 2022
- Volume 2022 eBook
- Issue 3
- Pages: 4–9
Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
Time-to-market remains a significant factor in drug development today, as delays in timelines can often have costly and damaging effects, not only to the drug developer but to the patient. Challenges in the drug development cycle arise early in the drug candidate screening process. In this article, Industry players discuss how technological innovation and advances in analytical approaches enhance early drug candidate screening workflows to help shorten drug discovery and development timelines.
Read
About the author
Feliza Mirasol is science editor for Pharmaceutical Technology.
Article Details
Pharmaceutical Technology
eBook: Trends in Formulation, October 2022
October 2022
Pages: 4–9
Citation
When referring to this article, please cite it as F. Mirasol, “Using a Drug Candidate Screening Strategy to Mitigate Late-Stage Risk," Pharmaceutical Technology Trends in Formulation eBook (October 2022).
Articles in this issue
about 3 years ago
Small is a Powerful Ingredient for Patient-Centric Formulationsabout 3 years ago
Addressing Developmental Challenges of Gene Therapy Viral Vectorsabout 3 years ago
Improved Formulations to Enable Stable Delivery of Biologicsabout 3 years ago
Nitrosamides–Should They Be Treated the Same as Nitrosamines?about 3 years ago
Emerging Applications of Vitamin E TPGS in Drug DeliveryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
